APA (7th ed.) Citation

J, B., K, D., H, Z., L, H., SA, L., L, S., . . . PA, B. (2015). Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. Clinical lung cancer, 16(6), e189. https://doi.org/10.1016/j.cllc.2015.05.002

Chicago Style (17th ed.) Citation

J, Bar, et al. "Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24." Clinical Lung Cancer 16, no. 6 (2015): e189. https://doi.org/10.1016/j.cllc.2015.05.002.

MLA (9th ed.) Citation

J, Bar, et al. "Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24." Clinical Lung Cancer, vol. 16, no. 6, 2015, p. e189, https://doi.org/10.1016/j.cllc.2015.05.002.